Autres langues Telix Pharmaceuticals Limited

Actions

TLX

AU000000TLX2

Recherche biotechnologique et médicale

Temps Différé Australian S.E. 03:43:42 24/09/2026			Varia. 5j.	Varia. 1 janv.
15,97 ^AUD	-0,68%		-8,31%	+42,86%

15/09	Telix Pharmaceuticals Limited : Jarden Research maintient sa recommandation à l'achat	ZM
15/09	Les prévisions de BPA de Telix augmentent d'environ 9% pour l'exercice 2027 et de 21% pour l'exercice 2028 après l'approbation d'un traitement contre le gliome, selon Jefferies	MT

Autres langues

22/09	ASX Preview: Australian Shares to Rise as Oil Prices Retreat; Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration
22/09	Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration
21/09	Telix to Buy Germany's ITM Isotope in Deal Worth Up to $2.35 Billion
21/09	Telix Pharmaceuticals Limited agreed to acquire ITM Isotope Technologies Munich SE for $2.3 billion .
21/09	Telix to Acquire Germany's ITM for $1.65 Billion
21/09	Australian shares end flat as miners offset gains in banks
21/09	MÄRKTE ASIEN/Freundlich - Sehr feste Samsung-Aktie treibt Kospi an
21/09	Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment
21/09	MÄRKTE ASIEN/Aktien freundlich - Ruhetag in Tokio - Ölpreis fällt weiter
21/09	MÄTKTE ASIEN/Aktien freundlich - Ruhetag in Tokio - Ölpreis fällt weiter
21/09	Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment, Shares Fall 3%
21/09	Australian shares edge lower as banks and miners drag
21/09	Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
21/09	Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion
20/09	Telix Pharmaceuticals Limited signed a strategic agreement to acquire ITM Isotope Technologies Munich SE for $2.3 billion.
18/09	Deals of the day-Mergers and acquisitions
15/09	Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says
15/09	Telix Pharmaceuticals' US FDA Approval for Brain Cancer Imaging Agent to Help Diversify Revenue Stream, Jarden Says
14/09	Telix Pharmaceuticals Limited Receives FDA Approval for Pixclara Brain Cancer Imaging Drug
14/09	Telix Pharmaceuticals Receives FDA Approval for Brain Cancer Imaging Drug Pixclara
14/09	Telix Pharmaceuticals Says US FDA Approves New Drug Application for Brain Cancer Imaging Drug
14/09	Telix Pharmaceuticals : FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
11/09	ASX Biggest Losers
09/09	Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
03/09	ASX Biggest Gainers